Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 44

Results For "Vaccines"

748 News Found

India’s pharma exports grow by 103% since 2013-14
News | May 01, 2022

India’s pharma exports grow by 103% since 2013-14

Pharma exports in 2021-22 sustain a positive growth despite global trade disruptions


Ross Prize awarded to mRNA technology, Covid-19 vaccine innovators
News | April 28, 2022

Ross Prize awarded to mRNA technology, Covid-19 vaccine innovators

University of Pennsylvania scientists Katalin Karikó and Drew Weissman to be honoured at June 7 symposium in New York City for their research that enabled Covid-19 vaccines


Sanofi continues to deliver strong business
News | April 28, 2022

Sanofi continues to deliver strong business

Business EPS of €1.94, up 20.5% on a reported basis and 16.1% at CER, also benefitting from an improved effective tax rate


Syngene full-year revenue from operations up 19% to Rs. 2604 crore
News | April 27, 2022

Syngene full-year revenue from operations up 19% to Rs. 2604 crore

Revenue from operations up 15% to Rs. 758 crore in fourth quarter


Drugs Controller clears Covaxin, Corbevax and ZyCov-D for kids
News | April 26, 2022

Drugs Controller clears Covaxin, Corbevax and ZyCov-D for kids

The approval by the DCGI comes following recommendations by the Subject Expert Committee (SEC) on Covid-19 of the Central Drugs Standard Control Organisation(CDSCO)


Thermo Fisher opens bioprocessing manufacturing site in Ogden, Utah
News | April 25, 2022

Thermo Fisher opens bioprocessing manufacturing site in Ogden, Utah

The $44 million facility is part of Thermo Fisher's $650 million multi-year investment, announced last year, to help ensure flexible, scalable and reliable bioprocessing production capacity exists for critical materials used in developing new and existing biologics and vaccines, including for COVID-19


CanSinoBIO rebrands to reflect commitment to life sciences research
Biotech | April 25, 2022

CanSinoBIO rebrands to reflect commitment to life sciences research

This is the first major brand refresh of CanSinoBIO since its inception in 2009


Shilpa Medicare receives NoC for biosimilar Aflibercept
Biotech | April 25, 2022

Shilpa Medicare receives NoC for biosimilar Aflibercept

Aflibercept is the second biosimilar product that has entered the clinical trial phase after biosimilar Adalimumab


Covid-19 vaccine protection against hospitalization wanes
News | April 23, 2022

Covid-19 vaccine protection against hospitalization wanes

Kaiser Permanente finds the Pfizer Covid-19 third dose vaccine protection against hospitalization from omicron wanes after 3 months


WHO recommends Paxlovid for Covid-19 therapy
News | April 22, 2022

WHO recommends Paxlovid for Covid-19 therapy

This recommendation is based on new data from two randomized controlled trials involving 3078 patients